Cart
sales@molnova.com
Ethyl mandelate
CAS No. 774-40-3
Ethyl mandelate( NSC 5307 | NSC-5307 | NSC5307 )
Catalog No. M27247 CAS No. 774-40-3
Ethyl mandelate is an intermediate of Pemoline with antimicrobial activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameEthyl mandelate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEthyl mandelate is an intermediate of Pemoline with antimicrobial activity.
-
DescriptionEthyl mandelate is an intermediate of Pemoline with antimicrobial activity.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 5307 | NSC-5307 | NSC5307
-
PathwayOthers
-
TargetOther Targets
-
RecptorAkt1| Akt2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number774-40-3
-
Formula Weight180.203
-
Molecular FormulaC10H12O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOC(=O)C(O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yamaji M, Ota A, Wahiduzzaman M, Karnan S, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y, Haniuda M. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27. PubMed PMID: 28960945; PubMed Central PMCID: PMC5673922.
molnova catalog
related products
-
Necroptosis-IN-3
Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-) (Compound 69) is a Necroptosis inhibitor that inhibits TNF-α induced necroptosis. Necroptosis-IN-3 (Compound STX1638) also inhibits 11β-HSD1.
-
[Val4]-Angiotensin I...
[Val4] Angiotensin III is an angiotension III peptide. [Val4] Angiotensin III is a potent full agonist of Gαq and βarr2 response, with pEC50 values of 8.31 and 8.44, respectively.
-
β-CGRP, human TFA (1...
β-CGRP,human tissue is one of the calcitonin peptide, through complex behavior of calcitonin receptor like receptor (CRLR) - and receptor activity - modifying proteins (increased), and 1 and 300 - nM CRLR IC50s/RAMP1 and CRLR/RAMP2 cells.
